Heron Therapeutics | HRTX - 流动资产

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 60.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	流动资产	更改		日
ALKERMES	USD 1.36B		570.52M	2026-03
Alnylam Pharmaceuticals	USD 4.22B		168.65M	2026-03
Amarin	USD 626.02M		23.87M	2026-03
ANI Pharmaceuticals	USD 747.08M		6.03M	2026-03
Anika Therapeutics	USD 93.56M		9.8M	2026-03
Arrowhead Research	USD 1.84B		665.36M	2026-03
Eisai	JPY 761.64B		79.24B	2026-03
Emergent BioSolutions	USD 679.5M		41.3M	2023-12
Esperion Therapeutics	USD 459.46M		3.11M	2026-03
GlaxoSmithKline	GBP 17.76B		251M	2026-03
Heron Therapeutics	USD 228.98M		9.08M	2026-03
Insmed	USD 1.61B		181.04M	2026-03
Ligand Pharmaceuticals	USD 865.42M		33.14M	2026-03
Merck	USD 35.02B		8.5B	2026-03
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Neurocrine Biosciences	USD 2.44B		86.6M	2026-03
Omeros	USD 69.65M		26.53M	2025-06
Pacira	USD 514.96M		33.01M	2026-03
Regeneron Pharmaceuticals	USD 18.21B		187.3M	2026-03
Roche Holding	CHF 38.73B		3.03B	2025-12
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
Ultragenyx Pharmaceutical	USD 657M		294M	2026-03
Veracyte	USD 522.17M		33.8M	2026-03
Vertex Pharmaceuticals	USD 11.73B		529.3M	2026-03